Antitauon -

The concept of "tauons" arises from the observation that misfolded tau protein isoforms can propagate through the brain in a characteristic pattern, similar to prions, driving the progression of conditions like Alzheimer's disease. Antitauon therapies aim to intervene in this process through several key mechanisms:

Stopping tau proteins from sticking together to form toxic seeds. antitauon

Current research focuses on both to combat these tauon species: Example Agents / Trials Passive Immunotherapy The concept of "tauons" arises from the observation

Small Phase I studies have shown ASOs are safe and can reduce aggregated tau. Current Challenges and Clinical Status Current Challenges and Clinical Status Promoting the removal

Promoting the removal of pathological tau via microglia or through intracellular degradation pathways like the proteasome. Key Therapeutic Strategies

Vaccines that stimulate the patient's own immune system to produce anti-tau antibodies. , ACI-35 Intracellular Targeting